CCRL2 and myelodysplastic syndrome: However, within the MDS/AML cell lines, the anti-CCRL2 ADC showed the highest cytotoxicity in TF-1 and F36P cells and the second to highest cytotoxicity in SKM1 cells (Fig. 2D–F).